Melanoma/Skin Cancer

Top Story

Rheumatic adverse effects of immune checkpoint therapy 'poorly recognized' in studies

May 22, 2018
In the Journals Plus

US cancer deaths continue to decline

May 22, 2018
Cancer deaths continue to decline among men, women and children in the United States, according to the Annual Report to the Nation on the Status of Cancer. Deaths due to…
Meeting News

Hypophysitis incidence high after ipilimumab therapy for melanoma

May 17, 2018
BOSTON — Among adults with melanoma treated with the CTLA-4 immune checkpoint inhibitor ipilimumab, nearly 13% developed hypophysitis after therapy, according to…
In the Journals Plus

Patients’ sex may impact efficacy of immune checkpoint inhibitors

May 17, 2018
The magnitude of benefit from immune checkpoint inhibitors for advanced cancer appeared sex dependent, with women experiencing less benefit, according to results from a…
More Headlines »
CME

Exploring New Immune Checkpoint Inhibitor Paradigms in Advanced Melanoma

This activity is supported by an educational grant from Bristol-Myers Squibb.

Early detection and appropriate management of melanoma is imperative for optimal clinical outcomes. For patients…
More »
Video

VIDEO: New data emerges for adjuvant treatment of melanoma

March 10, 2018
More »
Resource Centers
Immuno-Oncology Resource Center

Immuno-Oncology Resource Center